8-Cl-cAMP affects glioma cell-cycle kinetics and selectively induces apoptosis

Cancer Investigation

Volumn 20, Issue 7-8, 2002, Pages 972-982

  Grbovic, Olivera ^a,b   Jovic, Viktor ^c   Ruzdijic, Sabera ^a   Pejanovic, Vjera ^d   Rakic, Ljubisav ^d   Kanazir, Selma ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

^c INSTITUTE FOR ONCOLOGY AND RADIOLOGY OF SERBIA   (Serbia)

^d Valeant Pharmaceuticals International   (United States)

Author keywords

8 Cl cyclic AMP; Apoptosis; Cell cycle kinetics; Cyclin B1; Human glioma cells; p53

Indexed keywords

8 CHLOROADENOSINE 3',5' PHOSPHATE; CYCLIC AMP DERIVATIVE; CYCLIN B1; DNA;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL CYCLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL STRUCTURE; CONTROLLED STUDY; DNA DETERMINATION; DOSE RESPONSE; DRUG MECHANISM; FLOW CYTOMETRY; GENE EXPRESSION; GLIOMA; HUMAN; HUMAN CELL; KINETICS; PRIORITY JOURNAL;

8-BROMO CYCLIC ADENOSINE MONOPHOSPHATE; ANTINEOPLASTIC AGENTS; APOPTOSIS; BRAIN NEOPLASMS; CELL CYCLE; CYCLIN B; DNA PRIMERS; FLOW CYTOMETRY; G2 PHASE; GLIOMA; HUMANS; IN SITU NICK-END LABELING; KINETICS; MUTATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; S PHASE; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0036422967     PISSN: 07357907     EISSN: None     Source Type: Journal    
DOI: 10.1081/CNV-120005913     Document Type: Article

References (30)

1. Weller, M.; Schmidt, C.; Roth, W.; Dichgans, J. Chemotherapy of human malignant glioma: Prevention of efficacy by dexamethasone? Neurology 1997, 48, 1704-1709.
2. Kerr, J.F.; Winterford, C.M.; Harmon, B.V. Apoptosis its significance in cancer and cancer therapy. Cancer 1994, 73, 2013-2026.
3. Olashaw, N.E.; Pledger, W.J. Cellular mechanisms regulating proliferation. Adv. Second Messenger Phosphoprot. Res. 1988, 22, 139-173.
4. Cho-Chung, Y.S.; Pepe, S.; Clair, T.; Budillon, A.; Nestorova, M. CAMP-dependent protein kinase: Role in normal and malignant growth. Crit. Rev. Oncol.Hematol. 1995, 21, 33-61.
5. Cho-Chung, Y.S. Site-selective 8-chloro-cyclic adenosine 3'5'-monophosphate as a biologic modulator of cancer: Restoration of normal control mechanisms. J. Natl. Cancer Inst. 1989, 81, 982-987.
6. Cho-Chung, Y.S.; Clair, T.; Tortora, G.; Yokozaki, H. Role of Site-selective cAMP analogs in the control and reversal of malignancy. Pharmacol. Ther. 1991, 50, 1-33.
7. Rohlff, C.; Safa, B.; Rahman, A.; Cho-Chung, Y.S.; Klecker, R.W.; Glazerm, R.I. Reversal of resistance to adriamycin by 8-chloro-cyclic AMP in adriamycinresistant HL-60 leukemia cells is associated with reduction of type I cyclic AMP-dependent protein kinase and cyclic AMP response element-binding protein DNA-binding activities. Mol. Pharmacol. 1993, 43, 372-379.
8. 2-cAMP induce cell death independently of cAMP kinase-mediated inhibition of the G1/S transition in mammary carcinoma cells (MCF-7). Endocrinology 1995, 136, 2513-2520.
9. Tortora, G.; Tagliaferrim, P.; Clair, T.; Colamonici, O.; Neckers, L.M.; Robins, R.K.; Cho-Chung, Y.S. Site-selective cAMP analogs at micromolar concentrations induce growth arrest and differentiation of acute promyelocytic, chronic myelocytic, and acute lymphocytic human leukemia cell lines. Blood 1988, 71, 230-233.
10. Noguchi, K.; Murata, T.; Cho-Chung, Y.S. 8-Chloroadenosine 3′5′-monophosphate (8-Cl-cAMP) selectively eliminates protein kinase a type I to induce growth inhibition in c-ras-Transformed Fibroblasts. Eur. J. Cancer 1998, 34, 1260- 1267.
11. Gavrieli, Y.; Sherman, Y.; Ben-Sasson, S.A. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 1992, 119, 493-501.
12. Wong, H.; Anderson, W.D.; Cheng, T.; Riabowol, K.T. Monitoring mRNA expression by polymerase chain reaction: The "primer-dropping" method. Anal. Biochem. 1994, 223, 251 -258.
13. Lamb, P.; Crawford, L. Characterization of the human p53 gene. Mol. Cell. Biol. 1986, 6, 1379-1385.
14. Pesic, M.; Drabek, K.; Esler, C.; Ruzdijic, S.; Pejanovic, V.; Pietrzkowski, Z. Inhibition of cell growth and proliferation in human glioma cells and normal human astrocytes induced by 8-Cl-cAMP and tiazofurin. Nucleosides Nucleotides & Nucleic Acids 2000, 19, 963-975.
15. Pepe, S.; Tortora, G.; Noguchi, P.D.; Marti, G.E.; Washington, G.C.; Cho-Chung, Y.S. Effects of 8-Chloroadenosine 3′5′-Monophosphate and N6-Benzylcyclic Adenosine 5′-Monophosphate on Cell Cycle Kinetics of HL-60 Leukemia Cells. Cancer Res. 1991, 51, 6263 -6267.
16. Nurse, P. Universal control mechanism regulating onset of M-phase. Nature 1990, 344, 503-508.
17. Davis, T.W.; Wilson-Van Patten, C.; Meyers, M.; Kunugi, K.A.; Cuthill, S.; Reznikoff, C.; Garces, C.; Boland, C.R.; Kinsella, T.J.; Fishel, R.; Boothman, D.A. Defective expression of the DNA mismatch repair protein MLH1. Alters G2-M cell cycle checkpoint arrest following ionizing radiation. Cancer Res. 1998, 58, 767-778.
18. Choi, Y.H.; Zhang, L.; Lee, W.H.; Park, K.Y. Genistein-induced G2/M arrest is associated with the inhibition of cyclin B1 and the induction of p21 in human breast carcinoma cells. Int. J. Oncol. 1998, 13, 391-396.
19. Langeveld, C.H.; Jongenelen, C.A.; Theeuwes, J.W.; Baak, J.P.; Heimans, J.J.; Stoof, J.C.; Peters, G.J. The antiproliferative effect of 8-chloro-adenosine, an active metabolite of 8-chloro-cyclic adenosine monophosphate, and disturbances in nucleic acid synthesis and cell cycle kinetics. Biochem. Pharmacol. 1997, 53, 141-148.
20. Raaphorst, G.P.; Mao, J.; Yang, H.; Goel, R.; Niknafs, B.; Shirazi, F.H.; Yazdi, H.M.; Rippstein, P.; Ng, C.E. Evaluation of apoptosis in four human tumour cell lines with differing sensitivities to cisplatin. Anticancer Res. 1998, 18, 2945-2951.
21. Shiao, Y.H.; Lee, S.H.; Kasprzak, K.S. Cell cycle arrest, apoptosis and p53 expression in nickel (II) acetate-treated Chinese hamster ovary cells. Carcinogenesis 1998, 19, 1203-1207.
22. Piperski, V.; Vracar, M.; Jokanovic, M.; Stukalov, P.; Rakic, L. Detection of apoptosis and phagocytosis in vitro in C6 rat glioma cells treated with tiazofurin. Apoptosis 1998, 3, 345-352.
23. Shi, L.; Nishioka, W.K.; Th'ng, J.; Bradbury, E.M.; Litchfield, D.W.; Greenberg, A.H. Premature p34cdc2 Activation Required for Apoptosis. Science 1994, 263, 1143-1145.
24. Stewart, N.; Hicks, G.G.; Paraskevas, F.; Mowat, M. Evidence for a Second Cell Cycle Block at G2/M by p53. Oncogene 1995, 10, 109-115.
25. Bunz, F.; Dutriaux, A.; Lengauer, C.; Waldman, T.; Zhou, S.; Brown, J.P.; Sedivy, J.M.; Kinzler, K.W.; Vogelstein, B. Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science 1998, 282, 1497-1501.
26. Chan, T.A.; Hwang, P.M.; Hermeking, H.; Kinzler, K.W.; Vogelstein, B. Cooperative effects of genes controlling the G(2)/M checkpoint. Genes Dev. 2000, 14, 1584-1588.
27. Abrahamson, J.L.; Lee, J.M.; Bernstein, A. Regulation of p53-mediated apoptosis and cell cycle arrest by steel factor. Mol. Cell. Biol. 1995, 15, 6953-6960.
28. Kuerbitz, S.J.; Plunkett, B.S.; Walsh, W.V.; Kastan, M.B. Wild-type p53 Is a cell cycle checkpoint determinant following irradiation. Proc. Natl. Acad. Sci. USA 1992, 89, 7491-7495.
29. Agarwal, M.L.; Agarwal, A.; Taylor, W.R.; Stark, G.R. p53 controls both the G2/M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts. Proc. Natl. Acad. Sci. USA 1995, 92, 8493-8497.
30. Miyashita, T.; Reed, J.C. Tumor Suppressor p53 Is a Direct transcriptional activator of the human bax gene. Cell 1995, 80, 293-299.